A detailed history of D. E. Shaw & Co., Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 6,761,095 shares of MRK stock, worth $680 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
6,761,095
Holding current value
$680 Million
% of portfolio
0.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $487 Million - $565 Million
4,382,317 Added 184.23%
6,761,095 $768 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $44.2 Million - $47.5 Million
357,363 Added 17.68%
2,378,778 $294 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $47.7 Million - $55.6 Million
-421,015 Reduced 17.24%
2,021,415 $267 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $75.2 Million - $81.8 Million
750,290 Added 44.34%
2,442,430 $266 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $39 Million - $43.3 Million
378,731 Added 28.84%
1,692,140 $174 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $88 Million - $95.9 Million
-810,055 Reduced 38.15%
1,313,409 $152 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $80.9 Million - $90.3 Million
786,199 Added 58.79%
2,123,464 $226 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $108 Million - $138 Million
1,233,272 Added 1185.92%
1,337,265 $148 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $22.3 Million - $25.1 Million
-263,897 Reduced 71.73%
103,993 $8.96 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $26.1 Million - $29.6 Million
-312,737 Reduced 45.95%
367,890 $33.5 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $369,828 - $414,554
5,031 Added 0.74%
680,627 $55.8 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $208 Million - $260 Million
-2,871,462 Reduced 80.95%
675,596 $51.8 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $23.3 Million - $25.7 Million
-325,497 Reduced 8.41%
3,547,058 $266 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $417 Million - $461 Million
-5,930,639 Reduced 60.5%
3,872,555 $301 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $7.79 Million - $9.17 Million
-113,067 Reduced 1.14%
9,803,194 $756 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $288 Million - $320 Million
4,019,781 Added 68.17%
9,916,261 $811 Million
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $201 Million - $228 Million
-2,746,222 Reduced 31.78%
5,896,480 $489 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $241 Million - $274 Million
3,421,204 Added 65.52%
8,642,702 $668 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $184 Million - $255 Million
2,899,596 Added 124.88%
5,221,498 $402 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $131 Million - $148 Million
-1,692,417 Reduced 42.16%
2,321,902 $211 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $71.4 Million - $77.8 Million
-937,977 Reduced 18.94%
4,014,319 $338 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $70.8 Million - $82.7 Million
-1,013,455 Reduced 16.99%
4,952,296 $415 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $54.7 Million - $62.4 Million
785,979 Added 15.17%
5,965,751 $496 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $53.5 Million - $62.1 Million
-820,071 Reduced 13.67%
5,179,772 $396 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $160 Million - $188 Million
-2,778,310 Reduced 31.65%
5,999,843 $426 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $389 Million - $457 Million
-7,655,492 Reduced 46.58%
8,778,153 $533 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $136 Million - $158 Million
2,666,913 Added 19.37%
16,433,645 $895 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $286 Million - $342 Million
5,544,095 Added 67.42%
13,766,732 $775 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $482 Million - $519 Million
8,222,637
8,222,637 $526 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $255B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.